| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |